Close



Apr 24, 2024 04:05PM
Mar 26, 2024 07:03AM
Mar 26, 2024 07:03AM
Mar 15, 2024 06:42AM
Feb 27, 2024 12:06PM
Feb 27, 2024 08:40AM
Feb 27, 2024 07:03AM Viking Therapeutics (VKTX) Announces Positive Top-Line Results from Phase 2 VENTURE Trial of Dual GLP-1/GIP Receptor Agonist VK2735 in Patients with Obesity
Feb 27, 2024 07:03AM
Feb 27, 2024 07:00AM
Nov 8, 2023 04:01PM
Oct 23, 2023 07:05AM
Oct 17, 2023 04:22PM
Oct 17, 2023 04:05PM
Oct 10, 2023 04:05PM Viking Therapeutics to Highlight Data from Phase 1 Clinical Trial of Dual GLP-1/GIP Receptor Agonist VK2735 in Oral Presentation at ObesityWeek 2023
Sep 6, 2023 07:03AM
Aug 8, 2023 04:01PM
May 4, 2023 04:01PM
Mar 28, 2023 07:03AM
Mar 28, 2023 07:03AM
Mar 28, 2023 06:34AM
Mar 28, 2023 06:33AM Viking Therapeutics Announces Results from Phase 1 Clinical Trial of Dual GLP-1/GIP Receptor Agonist VK2735
Jul 27, 2022 04:05PM
Jul 19, 2022 07:02AM
Jul 19, 2022 07:02AM
Apr 28, 2022 06:19AM
Apr 27, 2022 04:08PM
Feb 9, 2022 04:05PM
Jan 24, 2022 07:02AM Viking Therapeutics (VKTX) Announces FDA's Clinical Hold on Phase 1b Trial of VK0214
Jan 24, 2022 07:02AM
Jan 10, 2022 07:02AM
Nov 1, 2021 07:04AM
Nov 1, 2021 07:03AM
Jun 24, 2021 07:06AM
Jun 24, 2021 07:05AM
Jun 17, 2021 07:05AM Viking Therapeutics (VKTX) Announces Results from Phase 1 Clinical Trial of Novel Oral Thyroid Receptor Beta Agonist VK0214
Jun 17, 2021 07:05AM
Sep 9, 2020 07:09AM
Sep 9, 2020 07:05AM
Jul 29, 2020 05:12PM
Jul 29, 2020 04:05PM
Feb 26, 2020 04:15PM
Nov 19, 2019 09:13AM Pre-Open 11/19: (MYOV) (MDCO) (VKTX) Higher (I) (KSS) (HD) Lower (more...)
Nov 19, 2019 07:06AM
Nov 19, 2019 07:05AM
Nov 5, 2019 07:03AM
Nov 5, 2019 07:00AM
Aug 1, 2019 04:44PM
Aug 1, 2019 04:05PM
Jun 24, 2019 04:21PM Stifel Starts Viking Therapeutic (VKTX) at Buy
Jun 11, 2019 09:28AM

251,815 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All